|
|
| | 7-chloro-8-hydroxy-1-(4'-(4-fluorobenzyl)thiophenyl)-3-methyl-2,3,4,5-tetrahydro-1H-3-benzazepine Basic information |
| Product Name: | 7-chloro-8-hydroxy-1-(4'-(4-fluorobenzyl)thiophenyl)-3-methyl-2,3,4,5-tetrahydro-1H-3-benzazepine | | Synonyms: | 7-chloro-8-hydroxy-1-(4'-(4-fluorobenzyl)thiophenyl)-3-methyl-2,3,4,5-tetrahydro-1H-3-benzazepine;1H-3-Benzazepin-7-ol, 8-chloro-5-[4-[[(4-fluorophenyl)methyl]thio]phenyl]-2,3,4,5-tetrahydro-3-methyl-;BT-Sch | | CAS: | 154540-50-8 | | MF: | C24H23ClFNOS | | MW: | 427.96 | | EINECS: | | | Product Categories: | | | Mol File: | 154540-50-8.mol |  |
| | 7-chloro-8-hydroxy-1-(4'-(4-fluorobenzyl)thiophenyl)-3-methyl-2,3,4,5-tetrahydro-1H-3-benzazepine Chemical Properties |
| | 7-chloro-8-hydroxy-1-(4'-(4-fluorobenzyl)thiophenyl)-3-methyl-2,3,4,5-tetrahydro-1H-3-benzazepine Usage And Synthesis |
| Description | BT-Sch is a dopamine D1 and D2 receptor-based imaging agent. |
| | 7-chloro-8-hydroxy-1-(4'-(4-fluorobenzyl)thiophenyl)-3-methyl-2,3,4,5-tetrahydro-1H-3-benzazepine Preparation Products And Raw materials |
|